Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication” - Chung-Feng Huang; Manar Hijaze Awad; Meital Gal-Tanamy; Ming-Lung Yu (Clinical and Molecular Hepatology, 2024)